188 related articles for article (PubMed ID: 27502996)
1. 2017 Clinical trials update in new treatments of β-thalassemia.
Makis A; Hatzimichael E; Papassotiriou I; Voskaridou E
Am J Hematol; 2016 Nov; 91(11):1135-1145. PubMed ID: 27502996
[TBL] [Abstract][Full Text] [Related]
2. Novel Therapeutic Advances in β-Thalassemia.
Makis A; Voskaridou E; Papassotiriou I; Hatzimichael E
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34207028
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
4. Recent trends in treatment of thalassemia.
El-Beshlawy A; El-Ghamrawy M
Blood Cells Mol Dis; 2019 May; 76():53-58. PubMed ID: 30792169
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
[TBL] [Abstract][Full Text] [Related]
6. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
Hamed EM; Meabed MH; Aly UF; Hussein RRS
Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of beta thalassemia--a guide to molecular therapies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
[TBL] [Abstract][Full Text] [Related]
8. Beta Thalassemia: Monitoring and New Treatment Approaches.
Khandros E; Kwiatkowski JL
Hematol Oncol Clin North Am; 2019 Jun; 33(3):339-353. PubMed ID: 31030806
[TBL] [Abstract][Full Text] [Related]
9. Towards more successful gene therapy clinical trials for β-thalassemia.
Drakopoulou E; Papanikolaou E; Georgomanoli M; Anagnou NP
Curr Mol Med; 2013 Sep; 13(8):1314-30. PubMed ID: 23865429
[TBL] [Abstract][Full Text] [Related]
10. Current and future alternative therapies for beta-thalassemia major.
de Dreuzy E; Bhukhai K; Leboulch P; Payen E
Biomed J; 2016 Feb; 39(1):24-38. PubMed ID: 27105596
[TBL] [Abstract][Full Text] [Related]
11. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.
Langer AL; Esrick EB
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):600-606. PubMed ID: 34889443
[TBL] [Abstract][Full Text] [Related]
12. Combination of a triple alpha-globin gene with beta-thalassemia in a gypsy family: importance of the genetic testing in the diagnosis and search for a donor for bone marrow transplantation for one of their children.
Yus Cebrian F; Recasens Flores Mdel V; Izquierdo Álvarez S; Parra Salinas I; Rodriguez-Vigil Iturrate C
BMC Res Notes; 2016 Apr; 9():220. PubMed ID: 27080228
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapies in β-thalassemia: toward a new era in management.
Bou-Fakhredin R; Tabbikha R; Daadaa H; Taher AT
Expert Opin Emerg Drugs; 2020 Jun; 25(2):113-122. PubMed ID: 32249632
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for homozygous beta-thalassemia. Is it a reality?
Boulad F; Rivière I; Sadelain M
Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
[TBL] [Abstract][Full Text] [Related]
16. Emerging Therapies.
Guerra A; Musallam KM; Taher AT; Rivella S
Hematol Oncol Clin North Am; 2018 Apr; 32(2):343-352. PubMed ID: 29458736
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of beta thalassaemia.
Origa R; Galanello R
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():263-70. PubMed ID: 21705976
[TBL] [Abstract][Full Text] [Related]
18. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis.
Matte A; De Falco L; Iolascon A; Mohandas N; An X; Siciliano A; Leboeuf C; Janin A; Bruno M; Choi SY; Kim DW; De Franceschi L
Antioxid Redox Signal; 2015 Dec; 23(16):1284-97. PubMed ID: 26058667
[TBL] [Abstract][Full Text] [Related]
19. The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
Rivella S
Blood Rev; 2012 Apr; 26 Suppl 1(0 1):S12-5. PubMed ID: 22631035
[TBL] [Abstract][Full Text] [Related]
20. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
Camaschella C; Nai A
Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
